Pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, read with Part A of Schedule III of the Regulations, Indraprastha Medical Corporation has informed that the management of the Company intends to engage in discussions with Investors/ Analyst Meet as on 24th June, 2025. Details enclosed.
The above information is a part of company’s filings submitted to BSE.